Surgical Treatment for Chest "Lock" Keloid Using Autologous Split-Thickness Skin Grafting and Postoperative Radiotherapy.
Dermatol Surg
; 49(5S): S64-S69, 2023 05 01.
Article
em En
| MEDLINE
| ID: mdl-37116003
ABSTRACT
BACKGROUND:
The treatment of chest "lock" keloids is challenging due to skin defects and a high recurrence rate.OBJECTIVE:
Evaluation of the effectiveness of autologous split-thickness skin graft with local radiotherapy for treating chest "lock" keloids. METHODSAND MATERIALS Fifty-seven patients with chest "lock" keloids were treated from July 2018 to September 2020. The skin defects were closed with an autologous split-thickness skin graft (STSG) and vacuum sealing drainage. The donor and the recipient sites received the first session of radiotherapy 72 hours postoperation for 3 consecutive days. Patients underwent follow-up examinations 12 months after surgery. The Patient and Observer Scar Assessment Scale (POSAS) was used to assess the treatment outcome.RESULTS:
Except for the complaints of pain, which did not improve in the patients' assessments (p = .368), POSAS improved significantly after treatment (p < .0001). The cure rate (including cured and partially cured scars) was 100%. No keloid recurrence was observed during the follow-up period.CONCLUSION:
The procedure of treating chest "lock" keloid by keloid debulking and autologous STSG followed by postoperational radiotherapy is a novel combined methodology for treating keloids.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Transplante de Pele
/
Queloide
Limite:
Humans
Idioma:
En
Ano de publicação:
2023
Tipo de documento:
Article